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Objective: To estimate the number of potential deceased organ donors in Canada and to 
determine the potential to achieve self-sufficiency in organ transplantation by comparing 
the number of estimated potential donors with the number of patients wait-listed for 
organ transplantation in Canada.  
Design: Retrospective analysis of information captured from hospital separations. 
Setting: Canadian provinces with the exception of Quebec between 2005-9. 
Participants: Persons ≤ 70 years of age who died in hospital. 
Main outcome measure: Potential donors (identified by the presence of diagnostic codes 
compatible with donation, the absence of contraindications to donation defined by 
Canadian Standards, and the use of mechanical ventilation). 
Results: Among 335,793 hospital deaths, 8,274 potential donors were identified. The 
study method was 81% sensitive and 93% specific for identification of potential donors, 
and overestimated potential donors by a factor of 1.6 -2.1 fold when compared to 
information from chart audits. After accounting for this overestimation, there are 
conservatively 400 unrecognized potential deceased donors in Canada annually. 
Conclusions: With 4000 patients wait-listed for transplantation and 400 unrecognized 
potential deceased donors annually, there is potential to achieve self-sufficiency in organ 
transplantation in Canada.   
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Introduction: 
In 2010, the World Health Organization (WHO) Global Consultation on Organ Donation 
and Transplantation(1) called for governments to move towards national self-sufficiency 
in transplantation, using their own resources to increase organ availability and reduce the 
need for transplantation by reducing chronic disease burden. Although the need to 
improve organ donation in Canada is well recognized, the number of deceased organ 
donors has remained relatively unchanged over the last decade. (2, 3) To what extent this 
stagnation is related to few potential deceased donors among patients who die in 
Canadian hospitals, or failure to identify and obtain consent for donation from potential 
deceased donors remains uncertain, and better information to understand this issue is 
urgently needed. 
The most commonly reported metric of deceased donation, the donor rate per million 
persons living in a region,(3) does not account for regional and secular differences in 
mortality, or for the cause of death among hospitalized patients,(4, 5) and therefore may 
lead to regions being misclassified as underperforming.(6) Despite these well-known 
limitations, donor rate per million continues to be the primary metric of the efficiency of 
organ donation services in Canada. The recommended gold standard method to determine 
the efficiency of deceased donation services utilized by countries with high donation 
rates, involves prospective audit of all in hospital deaths to determine the number of 
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potential donors followed by determination of the rate of conversion of potential donors 
to actual donors.(1, 7, 8) Implementation of this method is particularly challenging in 
Canada’s provincially administered health care system. Although chart audits are 
performed intermittently by regional organ procurement organizations, the criteria to 
define a potential donor are not standardized between regions. With more than 120,000 
deaths annually in Canadian hospitals,(9) and the absence of a national directive to 
collect this information it is unlikely that prospective national chart audits to identify 
potential donors will be implemented in Canada in the foreseeable future.  
 
The requirement for more informative metrics of the efficiency of deceased organ 
donation services prompted the current study with the following objectives: 1) to develop 
a practical and timely method to estimate the number of potential deceased donors using 
information already collected for patients who die in Canadian hospitals; 2) to determine 
the accuracy of this study method to identify potential deceased donors; 3) to compare the 
number of potential deceased donors identified by the study method with the number of 
actual deceased donors; and 4) to compare the number of unrecognized potential donors 
with information about the number of patients wait-listed for transplantation.  
 
Methods  
This is a retrospective analysis of in-hospital deaths captured in the Discharge Abstract 
Database (DAD) from 2005-9. The DAD contains demographic, administrative and 
clinical data for all acute care hospital separations, excluding emergency room 
admissions, and still births for all provinces and territories in Canada, excluding the 
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province of Quebec.(10) Diagnostic and procedural information in the DAD is recorded 
in a standardized format using International Statistical Classification of Diseases, 10th 
Revision, Canadian enhanced version (ICD-10-CA) and Canadian Classification of 
Health Intervention (CCI) codes.(10) 
Identification of potential donors (Figure 1). 
Consistent with the U.S. definition of a death eligible for donation,(11) we limited the 
analysis to persons who died in hospital that were ≤70 years of age. Among these 
persons, individuals with causes of death compatible with donation were identified using 
a limited number of International Classification of Diseases, Ninth Revision, Clinical 
Modification  (ICD-9-CM) codes (see Appendix A) as described by Holt and colleagues 
(the Canadian Institute for Health Information supplied a mapping of ICD-9-CM codes to 
ICD-10-CA codes that are recorded in the DAD). The use of these ICD-9-CM codes is 100% sensitive for identification of potential donors. (12) We further excluded individuals 
with absolute and relative contraindications to donation, as per the Canadian Standards 
Association (Appendix B).(13) With the understanding that donation is highly unlikely 
unless patients have access to critical care services, we further restricted our 
identification of potential donors to individuals for whom there was a procedural code for 
mechanical ventilation (Figure 1). The number of potential donors was calculated overall, 
by age group, and by province.   
 
Accuracy and validity of the study method  
The accuracy of our potential donor estimates was determined by comparison with 
potential donors identified in chart audits of in-hospital deaths (the putative gold 
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standard) performed by regional organ procurement organizations in British Columbia 
and Manitoba. In British Columbia, chart audit information was available from two major trauma hospitals in greater Vancouver between 2007-9; while in Manitoba, information from six Winnipeg area tertiary hospitals was available between 2005-9. Details of the chart audits are described in Appendix C. The British Columbia data contained patient identifiers and was linked to data in the DAD by the Canadian Institute of Health Information to permit determination of sensitivity and specificity of the study method to identify potential donors. This was not possible with the Manitoba data, as this information could only be provided in aggregate due to privacy restrictions.  
 
Conversion of potential donors to actual donors 
The donor conversion ratio represents the number of potential donors who were 
converted to actual donors (actual donors ÷ potential donors). We compared our 
estimates of the number of potential organ donors identified in the DAD with the number 
of actual organ donors recorded in the Canadian Organ Replacement Register (CORR) 
during the study period, to calculate the donor conversion ratio. CORR receives 
information annually for all deceased organ donors in Canada, directly from provincial or 
regional organ procurement organizations(14) and defines a deceased donor as an 
individual from whom ≥ 1 organ is transplanted. Donor conversion ratios were calculated 
by age group and by province. Provincial donor conversion ratios were standardized for 
age distribution using direct standardization,(15) using the age distribution of all DAD 
deaths as the standard population.  
This study received local hospital research ethics board approval and this manuscript is 
compliant with privacy regulations of the Canadian Institute for Health Information, 
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British Columbia Transplant and Manitoba Transplant. All analyses were performed 
using SAS 9.4 (Carey, NC). 
 
Results 
There were 335,793 patients who died in-hospital reported in the DAD during the study 
period, including 106,993 patients ≤70 years. After the exclusion of patients with causes 
of death not compatible with donation (N=80,820), patients with absolute or relative 
contraindications to organ donation (N= 11,353), and patients without a procedural code 
for mechanical ventilation (N=6,546), 8,274 potential donors (7.7% of all in-hospital 
deaths aged ≤ 70 years) were identified. The number of patients who died in-hospital and 
the steps in the study algorithm used to identify potential donors are shown by age group 
in Table 1. The proportion of potential donors among patients who died in hospital 
ranged from 5.8 % in patients 61-70 years to 19.5%, among patients aged 18-40 years.  
Accuracy and validity of the study method 
The British Columbia chart audit included 1,989 patients and identified 165 potential 
donors, among whom 35 were actual donors; while the Manitoba chart audit included  
3,247 patients and identified 126 potential donors, among whom 52 were actual organ 
donors (Table 2). Application of the study method in British Columbia identified 266 
potential donors among the 1,989 audited in-patient deaths (13%); while application of 
the study method in Manitoba identified 266 potential donors among 3,247 audited in-
hospital deaths (8%). The accuracy of the study method was higher in British Columbia 
(ratio of potential donors identified by the study method compared to potential donors 
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identified by chart audit was 1.6) than in Manitoba (ratio = 2.1), and was highest in 
younger age groups (Table 2). 
 
The study method was 81% sensitive and 93% specific for the identification of potential 
donors. All actual donors were identified as potential donors using the study method. The 
reasons why N =31 potential donors in the chart audits were not identified by the study 
method included exclusion of n =14 (44%) because of the presence of an ICD code for anemia as per the Canadian Standards Association list of contraindications to organ donation, exclusion of N =14 (44%) because of the absence of a code for mechanical ventilation in the DAD, and exclusion of N =4 (12%) because of the presence of a code for sepsis in the DAD. 
Conversion of potential donors to actual donors 
There were 1,209 actual deceased organ donors aged ≤ 70 identified in CORR during the 
study period for an estimated overall donor conversion ratio of 15% (1,209 actual ÷ 8,274 
potential donors) (Table 3). The donor conversion ratio varied by age, ranging from 5% 
in patients aged 61-70 years to 43% among patients < 18 years of age (Table 3). Figure 2 
shows that the provincial age-standardized donor conversion ratios varied two-fold across 
regions, from a low of 11% in British Columbia, to a high of 21% in Saskatchewan.  
 
After accounting for the overestimation of the study method, donor conversion ratios 
remained low. For example, in British Columbia the overall conversion ratio was 17.6% 
after accounting for the 1.6 fold difference in potential donors in the study method 
compared to the chart audit (11% conversion ratio X 1.6 correction for the overestimation 
of the number of potential donors using the study method).  Even after allowing for a 
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conservative 2.5 fold difference in potential donors identified by the study method 
compared to the chart audit in the entire data set, N =2,100 potential donors or 525 
donors per year were not converted to actual donors during the study period.   
Discussion  
Principal Findings 
Using routinely collected administrative data, we estimated that 7.7% of patients who 
died in-hospital aged ≤70 years are potential deceased donors. By comparison with 
information from chart audits, we found that the use of administrative data overestimated 
the number of potential donors by a factor of 1.6 - 2.1 fold. Assuming a conservative 2.5 
fold difference in the number of potential donors identified by use of administrative data 
and chart audit, the findings suggest that there are more than 800 potential donors (3.1 
potential donors per 100 in-hospital deaths among patients aged ≤70 years) in Canadian 
provinces per year (excluding Quebec). In the last year of study, there were 312 deceased 
organ donors aged ≤70 years in the Canadian provinces studied (there were 446 donors 
aged ≤70 years in all of Canada including Quebec),(16) indicating there are at least 400 
unrecognized potential donors in Canada annually. These findings suggest a significant 
opportunity to increase deceased organ donation in Canada.  
 
Strengths and weakness 
Countries with higher donation rates than Canada including the United States, the United 
Kingdom and Spain perform regular chart audits of patients dying in hospital to identify 
potential donors and their conversion to actual donors. Our study method to estimate 
potential donors using administrative data falls short of this standard and importantly 
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does not provide information about why potential donors are not converted to actual 
donors. In the absence of a national mandate and funding to complete these 
recommended chart audits, the study method provides a practical alternative to assess the 
efficiency of the deceased organ donor system in Canada and has recently been adopted 
by the Canadian Institute of Health Information as a supplement to the deceased donor 
rate per million population in their national report on organ donation and transplantation 
in Canada. (17) Importantly continued efforts to improve the study method are needed, 
including ongoing comparison with information from hospital chart audits and efforts to 
improve the assignment of diagnostic codes to hospitalized deaths in critical care areas. 
Our analysis was purposefully restricted to in-hospital deaths between 2005-9 because of 
the limited availability of regional chart audit data. However the number of deceased 
donors in Canada has remained relatively unchanged since 2009,(16) and a 2014 report 
from the Canadian Institute for Health Information confirmed a similar estimate of the 
number of potential donors in Canada using the DAD and the study algorithm, indicating 
that our findings likely remain applicable.(17) 
Comparison to other studies 
Previous studies of deceased organ donation in Canada were limited to regional analyses. 
A study from Ontario reported that 1 in 4 potential donors actually donated but the 
definition of a potential donor was restricted to individuals less than 59 years of age who 
survived in hospital for less than 1 week.(18) A recent study from Calgary suggested few 
critically ill patients with severe brain injuries qualify as potential donors. (19) However, 
the study relied on electronic charting of a neurological diagnosis of brain death to 
identify potential donors, and it was unclear how often patients were in fact evaluated for 
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neurologic brain death, or how complete the capture of brain death diagnoses were in the 
electronic charts used in the study.(19)  
Implication of Study Findings 
In the United States approximately 5% of the 210,000 patients ≤ 70 years who die in 
hospital are potential donors, and over 70% of these potential donors actually donate 
organs. (6, 20, 21) There are important differences between the organization of organ 
donation services in Canada and the United States that may contribute to these 
differences in donation. In the U.S, the federal government reimburses costs associated 
with deceased organ donation on a cost recovery basis, and transparent reporting of organ 
donation metrics is required. In contrast, in Canada there is considerable variation in the 
amount hospitals are reimbursed for supporting organ donation services in different 
provinces, and there is no federal mandate for reporting.(3) Although the rate of deceased 
organ donation in Canada lags behind that in the United States, evaluation of each 
country’s ability to meet its citizen’s need for organ transplantation requires a broader 
examination of both the incidence of end organ failure and allograft survival.  Using end 
stage renal disease (ESRD) as an example, the ESRD incidence in the United States (350 
per million) is over twice that in Canada (160 per million), while 5 year survival of first 
deceased kidney transplants recipients in the United States is 72% compared to 83% in 
Canada.(16, 22) Accordingly 32% of all prevalent ESRD patients in the United States < 
75 years are treated with transplantation (35% < 65 years) compared to 50% in Canada 
(55% < 65 years).(16, 23) Although some of these discrepancies are related to differences 
in population characteristics and perhaps access to renal replacement therapy between the 
countries, the differences nonetheless illustrate the relevance of the self-sufficiency 
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concept as advanced by the WHO. An important implication of these differences is that 
there may be sufficient potential donors to meet the need for organ transplantation in 
Canada (approximately 4000 wait-listed patients and 400 unrecognized potential donors 
annually).(24) In contrast efforts to increase the conversion of potential donors to actual 
in the United States (over 120 000 wait-listed patients and only 2000 to 3000 
unrecognized potential donors per annum)(21, 22, 25-29) may be insufficient to achieve 
self-sufficiency without a significant effort to decrease the incidence of ESRD.   
 
The potential for improvement in donor conversion is not unique to Canada. Similar 
observations were made in the United Kingdom via its Potential Donor Audit by the 
Government's Organ Donation Taskforce in 2008.(30) The Taskforce concluded that it 
was essential for clinical staff to be offered a clear ethical framework and clinical 
guidelines through which to ensure consistency of practice across the UK.(31, 32) These 
initiatives, alongside other improvements to donation and transplantation infra-structure 
led to a 50% increase in the number of deceased donors during 2008-2013.(33)  
 
Future research 
 
The transparent reporting of potential donors using the study method is an important first 
step in improving deceased organ donation in Canada.  Future research will focus on 
understanding why potential donors are not converted to actual donors, and 
demonstrating improvements in organ donation by sharing of best practices between high 
and low performing regions identified by the study method.  
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Figure 1- A flow chart describing the study method used to refine the estimate of the 
number of potential deceased organ donors 
 
 
 
 
Figure 2- The number of potential donors, actual donors and the age-standardized donor 
conversion ratio by province. (BC=British Columbia; AB=Alberta; SK=Saskatchewan; 
MB=Manitoba; ON=Ontario; NS=Nova Scotia, New Brunswick, Prince Edward Island 
and Newfoundland) 
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Table 1- Identification of potential donors using the study method 
 Age Group (years) 
 All 
patients  
≤ 70 
<18 18-40 41-50 51-60 61-70 
In-hospital 
deaths (N) 
106 993 6 267 6 381 12 942 29 814 51 589 
ICD diagnoses 
codes compatible 
with organ 
donation 
26 173 1 140 2 822 3 739 7 078 11 394 
Without 
contraindication 
to transplantation 
as per Canadian 
Standards 
Association 
14 820 570 1 742 2 088 3 876 6 544 
Potential organ 
donors 
(mechanically 
ventilated)  
8 274 
(7.7%) 
419 
(6.7%)* 
1 245 
(19.5%) 
1 381 
(10.7 %) 
2 232 
(7.5%) 
2 997 
(5.8%) 
* Percentage of in-hospital patient deaths identified as potential donors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 2- Number of Potential Donors Identified by Chart Audit and the Study Method  
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British Columbia Chart Audit Age*** Potential Donors in Chart Audit Potential Donors in DAD by Study Method 
Ratio of Potential Donors Identified with Study Method Compared to Chart Audit 
Total 165* 266 1.6 
<18 years 2 2 1.0 
18-40 years 53 66 1.2 
41-50 years 33 50 1.5 
51-60 years 42 70 1.7 
61-70 years 34 78 2.3 Manitoba Chart Audit 
Total 126* 266 2.1 
<18 years** 11 14 1.3 
18-40 years 39 44 1.1 
41-50 years 26 53 2.0 
51-60 years 29 67 2.3 
61-70 years 18 88 4.9 *1 individual missing age data in British Columbia chart audit; 3 individuals missing age data in Manitoba chart audit ** Conversion ratios by age could not be determined for the Manitoba chart audit as only aggregate information regarding the total number of donors was obtained. *** Validation data was not available for in-hospital deaths aged > 70 years. 
 
 
Table 3- The Conversion of Potential Donors to Actual Donors by Age Group 
 Age Group (years) 
N All patients 
≤70 
<18 18-40 41-50 51-60 61-70 
Potential donors  8 274 419  1 245 1 381 2 232 2 997 
Actual Donors 1 209 181 322 281 285 140 
Donor 
Conversion 
Ratio  
15% 43% 26% 20% 13% 5% 
21  
Appendix A. Diagnostic inclusion codes for eligible causes of death. 
Diagnosis Description ICD-10-CA Diagnostic Codes  
Head Injury  
Intracranial injury  S06.2, S06.3, S06.4, S06.5, S06.6, 
S06.8, S06.9, S02.001, S02.101, 
S02.701, S02.891 
Cerebrovascular Accident (CVA)  
Subarachnoid haemorrhage I60 
Intracerebral haemorrhage I61 
Other intracranial haemorrhage I62 
Occlusion or stenosis of precerebral/ cerebral arteries I63, I65, I66 
Stroke, not specified as haemorrhage or infarction I64 
Other  
Central nervous system tumours C70, C71, C72 
Anoxic brain damage G93.1 
Compression of brain G93.5 
Cerebral oedema G93.6, S06.1 
Ventricular tachycardia I47.2 
Ventricular fibrillation and flutter I49.00, I49.01 
Cardiac arrest I46.0,  I46.1, I46.9 
Status asthmaticus J45.01, J45.11, J45.81, J45.91 
Asphyxia R09.0 
Respiratory arrest R09.2 
Asphyxiation and strangulation T71   Appendix B. Diagnostic exclusion codes for contraindications to organ donation 
Diagnosis Description  ICD-10-CA Diagnostic Codes  
Death, unknown cause R96, R98, R99 
Nervousness, Malaise and fatigue R45.0, R53 
Cachexia R64 
Other specified general symptoms and signs R68.8 
Unknown and unspecified causes of morbidity R69 
Tuberculosis A15-A19, O98.0 
Sepsis A40-A41, A03.9, A20.7, A21.7, A24.1, A26.7, 
A28.0, A28.2, A32.7, A42.7, B37.7, O03.0, O03.5, 
O04.0, O04.5, O05.0, O05.5 O07.3, O08.0, T80.2, 
T81.4, T88.0, T82.6, T82.7, T83.5, T83.6, T84.5-, 
T84.6-, T85.7, R65.0, R65.1, R65.9, A22.7, A02.1, 
O85 
Brucellosis/ Listeriosis A23/ A32 
Other infection during labour O75.3 
Acute and chronic meningococcaemia A39.2, A39.3 
Meningococcaemia, unspecified A39.4 
Human immunodeficiency virus [HIV] B24, Z20.6, Z21, R75, O98.7 
Cytomegaloviral disease B25 
Acute poliomyelitis A80 
Jakob-Creutzfeldt disease A81.0, F02.1 
Normal-pressure hydrocephalus A81.1 
Subacute sclerosing panencephalitis G91.2 
Other rickettsioses A79 
Progressive multifocal leukoencephalopathy A81.2 
Disseminated herpesviral disease B00.7 
Viral encephalitis G04.0, G04.8, A85, A88.8, A86, A89, B00.0-4, A83, 
A84, A85.2, G05.1, G05.2, G04.9 
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Hepatitis B16, B17, B18, B19, O98.3, O98.4-9 
Rabies A82-A89 
Malaria B50-B54 
Active Syphilis A50-A53, O98.1 
Gonococcal infections A54, O98.2 
Other and unspecified mycoses B48, B49 
Malignant neoplasms C00-C96 
Haemolytic anemias 
Aplastic and other anemias 
D55-D59 
D61, D62, D64 
Meningitis (bacterial/viral) G00, G01, G02, G03, G05.2, B45.1, B83.2, A87 
Alzheimer’s disease G30 
Parkinson’s disease 
Motor neuron disease 
Multiple sclerosis 
G20 
G12.2 
G35 
Active endocarditis I33.0, I33.9, I01.1, I52.0 
Mixed connective tissue disease M32, M33, M34, M35 
Certain conditions with origin in perinatal 
period 
P00-P96 
Radiotherapy or chemotherapy session  Z51.0,  Z51.1 
Hypopituitarism E23.0 
Transplanted organ and tissue status Z94 
Presence of heart valve Z95.2, Z95.3, Z95.4 
Severe acute respiratory syndrome U04.90, U04.91 
West Nile virus/ Lyme disease A92.3/ A69.2 
Resistance to antibiotics U82, U83 
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Appendix C- Overview of chart audit methodology  
British Columbia Transplant: Death reports are received from critical care areas and the 
emergency room. Each death is reviewed for determination of GIVE criteria (Glasgow 
Coma Score <5, Injury to the brain, Ventilation, and End of life consideration). A chart 
review of each patient that meets the GIVE criteria is performed to determine organ 
donation potential. 
 
Manitoba Transplant: During the study period there were two methods used to identify 
which chart to review to identify potential donors: 1) retrospective use of ICD codes of 
patients who died in-hospital, and 2) real-time audit of all in-hospital deaths. Each chart 
was reviewed for death criteria, contraindications for donation and presence of 
mechanical ventilation.  
 
 
 
 
